Search

everythinglearnresearchcommunity

for

Search:↓

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

Progesterone treatment improved seizures in a woman with menstrual cycle-related epilepsy, but a wrong medication worsened her condition.

Doctors are preparing to potentially perform uterus transplants in transgender women, considering technical, hormonal, and ethical factors.

Transepidermal drug delivery effectively treated areata alopecia with minimal side effects.

17α-estradiol extends lifespan and improves metabolism in male mice through the estrogen receptor α.

Certain hormones can reduce skin oil and hair growth, potentially helping treat acne and excessive hair in women.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

Dermatologists are important in helping transgender people with skin issues and physical changes during their transition.

Testosterone helps prevent skin damage in males by acting through both estrogen and androgen pathways.

The treatment temporarily improved symptoms of hyperandrogenism in adolescents.

DHEA therapy improved pubic hair growth and psychological well-being in young females with adrenal insufficiency.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

Cyproterone acetate improves skin symptoms and quality of life in women with androgen-related issues.

Diphenyl ethers can potentially reduce excess oil production when applied on the skin, helping treat conditions like acne.

Both treatments reduced androgen levels and hair growth in women with hirsutism.

Thermoresponsive nanogels show promise for delivering medicine through the skin but need more safety testing and regulatory approval before clinical use.

Low-dose topical alpha-terthienyl may be a safer option for treating skin conditions with light therapy.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

Low-dose oral contraceptives reduced hair growth and testosterone levels in women with polycystic ovary syndrome.

Uterine transplants for transgender women are feasible but need more research.

Testosterone affects androgen receptors and lipid storage in cells, while DHEA does not convert to testosterone or affect these receptors in the same way.

Combination therapy significantly reduces testosterone and moderately reduces hair growth in women with hirsutism.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

Dutasteride and minoxidil helped regrow hair in a woman with breast cancer.

The trial on testosterone replacement therapy in older men faced concerns due to prostate cancer risk.

Menopause affects skin and hair, and more research is needed for effective treatments.

TRASER effectively targets blood vessels and hair follicles for potential use in vascular and hair removal treatments.

Hair lotions with 17 alpha-estradiol can reduce hair loss but won't regrow new hair.

Combining 5α-reductase and aromatase inhibitors may better reduce estrogen levels.